Tofacitinib in the Treatment of Rheumatoid Arthritis-related Interstitial Lung Disease.
Clinical trial NCT05246293 · UNKNOWN
Trial details
- NCT number
- NCT05246293
- Sponsor
- National Institute of Respiratory Diseases, Mexico
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-08
- Primary completion
- 2024-03-02
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.